Omidenepag

Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension. Omidenepag was approved for medical use in Japan in 2018, and in the United States in September 2022.
Wikipedia contributors, "Omidenepag", Wikipedia, revision 1377082348, retrieved 20 November 2026, source, CC BY-SA 4.0.